Phibro Animal Health (PAHC) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Phibro Animal Health (PAHC) do?
Phibro Animal Health Corp (PAHC) is a U.S.-listed company in Healthcare (Drug Manufacturers - Specialty & Generic). What it does: Manufactures and markets medicated feed additives, nutritional supplements, and vaccines for food-producing animals. It is worth $1.38B on the market and sold $1.54B over the last year.
- Market cap
- $1.38B
- P/E ratio
- 13.6×
- Annual sales
- $1.54B
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Brief updated
- Nov 17, 2026
Brands and businesses behind PAHC
- OmniGen: Nutritional feed specialty for dairy cattle that generates revenue through recurring sales to commercial dairy farms.
- Mecadox: Medicated feed additive for swine that generates revenue by controlling bacterial infections in nursery pigs.
- Animate: Anionic mineral supplement for dairy cows that generates revenue through sales to dairy nutritionists and farms.
- Stafac: Medicated feed additive for poultry and livestock that earns income through sales to commercial animal producers.
PAHC’s flags, in plain English
Each flag is a number from Phibro Animal Health’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 17, 2026.
Insiders Hold
Insiders own 48.5% of the company. The people who run the company own a meaningful slice of it, so they gain or lose along with other shareholders.
Stupid Cash
Can pay this year's bills 3.2 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Earns Its Keep
Earns 28.2% a year on shareholders' money. The company earns a healthy return on the money its shareholders have put in.
Debt Is Driving
Heavy debt, 189% of shareholder equity. The company owes a lot compared with what it earns. Lenders get paid before shareholders, which leaves management fewer options in a weak year.
2 more green flags and 1 more risk note open with the free trial. Try it free for 7 days.
Questions about PAHC
How big is Phibro Animal Health?
Phibro Animal Health’s market cap is $1.38B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $1.54B: what customers paid the company over the last year, before any costs.
What is PAHC’s P/E ratio?
PAHC’s P/E ratio is 13.6×. Investors pay about 13.6 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with PAHC?
Regulatory restrictions on the use of medically important antibiotics in food animals limit sales of traditional antibacterial products. That is one risk on Phibro Animal Health’s card. Its first risk flag is Debt Is Driving, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Phibro Animal Health’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. PAHC’s filings on SEC.gov. The Margin Monkey is research, not advice.
